A SWITCH TO BELATACEPT-BASED IMMUNOSUPPRESIVE REGIMEN IN KIDNEY TRANSPLANT RECIPIENTS FROM CALCINEURIN INHIBITORS (CNI) HAS A FAVOURABLE SAFETY PROFILE AND RESULTS IN IMPROVED RENAL FUNCTION: 12-MONTH RESULTS FROM A PHASE II STUDY

被引：0
|
作者：
Walker, R. G. [1 ]
Rostaing, L. [2 ]
Nainan, G. [3 ]
Rial M, Del C. [4 ]
Steinberg, S. [5 ]
Vincenti, F. [6 ]
Shi, R. [7 ]
Di Russo, G. [7 ]
Thomas, D. [7 ]
Xinos, C. [8 ]
Grinyo, J. [9 ]
机构：
[1] Royal Melbourne Hosp, Melbourne, Vic, Australia
[2] Univ Hosp, Toulouse, France
[3] Lakeshore Hosp, Cochin, Kerala, India
[4] Inst Nefrol, Buenos Aires, DF, Argentina
[5] Sharp Mem Hosp & Rehabil Ctr, San Diego, CA USA
[6] UCSF, San Francisco, CA USA
[7] Bristol Myers Squibb, Princeton, NJ USA
[8] Bristol Myers Squibb, Melbourne, Vic, Australia
[9] Univ Hosp Bellvitge, Barcelona, Spain
来源：
IMMUNOLOGY AND CELL BIOLOGY | 2011年 / 89卷 / 07期
关键词：
D O I：
暂无
中图分类号：
Q2 [细胞生物学];
学科分类号：
071009 ; 090102 ;
摘要：
引用
收藏
页码：A3 / A3
页数：1
相关论文
共 50 条
  • [1] Switch from a CNI- to a Belatacept-Based Immunosuppressive Regimen in Kidney Transplant Recipients Is Safe and Results in Better Renal Function: 12 Month Results from a Phase II Study.
    Rostaing, L.
    Nainan, G.
    Rial, M. del C.
    Steinberg, S.
    Vincenti, F.
    Shi, R.
    Di Russo, G.
    Thomas, D.
    Grinyo, J.
    AMERICAN JOURNAL OF TRANSPLANTATION, 2010, 10 : 90 - 90
  • [2] Belatacept in kidney transplant recipients switched from calcineurin inhibitors: results on renal function and safety after 6 months
    Bardo, P.
    Berdougo, B.
    Rouimi, E.
    Grimbert, P.
    Astier, A.
    Paul, M.
    INTERNATIONAL JOURNAL OF CLINICAL PHARMACY, 2013, 35 (06) : 1301 - 1302
  • [3] Switching from Calcineurin Inhibitor-based Regimens to a Belatacept-based Regimen in Renal Transplant Recipients: A Randomized Phase II Study
    Rostaing, Lionel
    Massari, Pablo
    Garcia, Valter Duro
    Mancilla-Urrea, Eduardo
    Nainan, Georgy
    del Carmen Rial, Maria
    Steinberg, Steven
    Vincenti, Flavio
    Shi, Rebecca
    Di Russo, Greg
    Thomas, Dolca
    Grinyo, Josep
    CLINICAL JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY, 2011, 6 (02): : 430 - 439
  • [4] Calcineurin inhibitor-free immunosuppression with belatacept (LEA29Y) in renal transplant: Phase II 12-month results.
    Larsen, C
    Charpentier, B
    Wekerle, T
    Blancho, G
    Zhou, W
    Levy, E
    Vincenti, F
    AMERICAN JOURNAL OF TRANSPLANTATION, 2005, 5 : 293 - 293
  • [5] ACUTE REJECTION BY BELATACEPT DOSING FREQUENCY: RESULTS FROM A PHASE II STUDY OF KIDNEY TRANSPLANT RECIPIENTS
    Vincenti, F.
    Blancho, G.
    Durrbach, A.
    Grannas, G.
    Grinyo, J.
    Meier-Kriesche, U.
    Polinsky, M.
    Zhao, H.
    Larsen, C.
    TRANSPLANT INTERNATIONAL, 2016, 29 : 9 - 9
  • [6] BETTER RENAL FUNCTION WITH EARLY EVEROLIMUS (EVL) INTRODUCTION AND CALCINEURIN INHIBITOR (CNI) WITHDRAWAL AT THIRD MONTH IN KIDNEY RECIPIENTS AT MONTH 12: RESULTS OF THE ERIC STUDY
    Rulz, J. C.
    Sanchez Fructuoso, A.
    Hernandez, D.
    Sanchez Plumed, J.
    Fernandez, A.
    Pastor Rodriguez, A.
    Paul, J.
    Alarcon, A.
    TRANSPLANT INTERNATIONAL, 2011, 24 : 112 - 112
  • [7] EFFICACY AND SAFETY OF TOFACITINIB (CP-690,550)-BASED CNI-FREE REGIMEN IN DE NOVO KIDNEY TRANSPLANT PATIENTS: 12-MONTH RESULTS OF A PHASE IIB STUDY
    Philip, O'Connell
    Solomon, Cohney
    Graeme, Russ
    Josette, Eris
    John, Kanellis
    Flavio, Vincenti
    Helio, Tedesco Silva
    Stephan, Busque
    Nervin, Lawendy
    Gary, Chan
    IMMUNOLOGY AND CELL BIOLOGY, 2012, 90 (08): : A29 - A29
  • [8] Effect of Everolimus with Reduced Calcineurin Inhibitor on Efficacy and Safety in De Novo Kidney Transplant Recipients: 12-Month Results from the US Cohort of TRANSFORM Study.
    Mulgaonkar, S.
    Qazi, Y.
    Kim, D.
    Peddi, V.
    McCague, K.
    Patel, D.
    Wiseman, A.
    AMERICAN JOURNAL OF TRANSPLANTATION, 2018, 18 : 259 - 259
  • [9] RENAL FUNCTION AT 2 YEARS IN KIDNEY TRANSPLANT RECIPIENTS SWITCHED FROM CYCLCOSPORINE OR TACROLIMUS TO BELATACEPT: RESULTS FROM THE LONG-TERM EXTENSION OF A PHASE II STUDY
    Grinyo, Josep
    Nainan, Georgy
    del Carmen Rial, Maria
    Steinberg, Steven
    Vincenti, Flavio
    Dong, Yuping
    Thomas, Dolca
    Kamar, Nassim
    TRANSPLANT INTERNATIONAL, 2011, 24 : 70 - 70
  • [10] Renal Function at 2 Years in Kidney Transplant Recipients Switched from Cyclosporine or Tacrolimus to Belatacept: Results from the Long-Term Extension of a Phase II Study
    Grinyo, J.
    Nainan, G.
    Rial, M.
    Steinberg, S.
    Vincenti, F.
    Dong, Y.
    Thomas, D.
    Kamar, N.
    AMERICAN JOURNAL OF TRANSPLANTATION, 2011, 11 : 99 - 99
12345